Gardasil 9 for Treatment of Existing Genital Warts
Gardasil 9 is not effective for treating existing genital warts and should not be used as a therapeutic intervention for active HPV infections. 1, 2
Mechanism and Purpose of Gardasil 9
Gardasil 9 is a prophylactic vaccine designed to prevent HPV infections, not treat existing ones. It works by:
- Creating immunity against 9 HPV types (6,11,16,18,31,33,45,52, and 58)
- Preventing initial infection with these HPV types
- Providing protection against future HPV-related diseases including genital warts and various cancers
The vaccine contains virus-like particles (VLPs) that stimulate antibody production but cannot cause infection as they contain no viral DNA.
Evidence on Treatment vs. Prevention
Treatment Limitations:
- Gardasil 9 has no therapeutic effect on existing HPV infections or HPV-related lesions 2
- The CDC and other guidelines clearly state that HPV vaccines are preventive, not therapeutic 1
- Treatment options for existing genital warts include topical medications, cryotherapy, surgical removal, and other modalities - not vaccination 1
Prevention Benefits:
- Gardasil 9 protects against HPV types 6 and 11, which cause approximately 90% of genital warts 1
- The vaccine is most effective when administered before exposure to HPV 1
- Even in individuals with existing HPV infection, the vaccine may provide protection against HPV types not yet acquired 2
Vaccination Recommendations
Age-Based Recommendations:
- Routine vaccination for all individuals aged 9-26 years 1, 2
- For ages 9-14: 2-dose schedule (0,6-12 months) 2
- For ages 15-26 or immunocompromised individuals: 3-dose schedule (0,1-2,6 months) 2
- Shared decision-making for ages 27-45 years 2
- Not authorized for individuals over 45 years 2
Special Populations:
- Men who have sex with men (MSM) and immunocompromised individuals should be vaccinated through age 26 years 1
- Vaccination should be given regardless of history of abnormal Pap tests, HPV infection, or genital warts 1
Management of Existing Genital Warts
For individuals with existing genital warts, appropriate treatment options include:
- Patient-applied treatments: imiquimod, podofilox, sinecatechins
- Provider-administered treatments: cryotherapy, trichloroacetic acid, surgical removal, laser therapy
- Genital warts may resolve spontaneously without treatment in some cases 1
Important Clinical Considerations
- Genital warts commonly recur after treatment, especially in the first 3 months 1
- HPV can be transmitted even when no visible warts are present 1
- Correct and consistent condom use may lower transmission risk but is not fully protective 1
- Individuals with genital warts should inform current sexual partners 1
Research Note
While one small case series suggested potential benefit of HPV vaccination for recalcitrant genital warts 3, this finding is not supported by major guidelines or larger studies, and contradicts the established mechanism of action of the vaccine. Current guidelines maintain that HPV vaccines are preventive, not therapeutic.
Conclusion for Clinical Practice
When patients present with existing genital warts, clinicians should:
- Provide appropriate treatment options for the warts themselves
- Consider HPV vaccination to prevent future infections with other HPV types
- Clearly communicate that the vaccine will not treat the current infection or warts
- Continue appropriate screening according to guidelines regardless of vaccination status